Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples